
  Cell </>

Switch Journal

    * Home <http://www.cell.com/>
    * Search <http://www.cell.com/search>
    * Archive <http://www.cell.com/content>
    * Subscribe <http://www.cell.com/subscribe>
    * Feedback <http://www.cell.com/popup/feedback>

    * Email Alerts <http://www.cell.com/personalize/emailalerts>
    * RSS <http://www.cell.com/misc/page?page=feeds>
    * Help <http://www.cell.com/popup/help/>
    * Jobs <http://www.sciencejobs.com>
    * Cell Press <http://www.cellpress.com/>

Register
<https://www.cell.com/personalize/register>LoginPasswordAuto-LoginPassword
Reminder <http://www.cell.com/personalize/forgotten>

Title/abstract/keywords   Author   Volume   First Page  

Click here!
<http://ad.uk.doubleclick.net/click;h=v8/3648/0/0/%2a/d;163649295;0-0;0;11386421;3454-728/90;24149695/24167548/1;;~sscs=%3fhttp://www.idtdna.com/Catalog/CustomGeneSyn/Page1.aspx>


*Information for Authors*

* *

[Downloadable PDF
<http://images.cell.com/images/EdImages/Information%20for%20AuthorsPDF2.pdf>]

/Cell/ was launched in 1974 as the journal of exciting biology.  Now a
part of Cell Press, a family of ten journals, /Cell/ maintains editorial
independence from its sister journals.  /Cell/’s Ph.D.-trained
scientific editors work with authors, reviewers, and editorial board
members with the goal of publishing 26 issues of the most interesting
discoveries in biology every year, including an annual Review Issue. 
Every paper published in /Cell/ is freely available starting 12 months
after publication.

Sections:

*Aims and Scope <http://www.cell.com/misc/page?page=authors#Aims>*

*Editorial Process
<http://www.cell.com/misc/page?page=authors#EditorialProcess> *

*Transfer of Papers between Cell Press Journals
<http://www.cell.com/misc/page?page=authors#Transfer>*

*Editorial Policies <http://www.cell.com/misc/page?page=authors#Policies> *

*Copyright <http://www.cell.com/misc/page?page=authors#Copyright>*

*Prepublication Policies
<http://www.cell.com/misc/page?page=authors#Prepublication> *

*Presubmission and Status Inquiries
<http://www.cell.com/misc/page?page=authors#Presubmission>*

*Research Article Formats
<http://www.cell.com/misc/page?page=authors#RAformats>*

*Preparation and Online Submission
<http://www.cell.com/misc/page?page=authors#SubmissionRA> *

*Organization of Article Sections
<http://www.cell.com/misc/page?page=authors#Sections> *

*Acceptable Figure File Formats for Submission
<http://www.cell.com/misc/page?page=authors#ImagesSUB>*

*Submission of Revised Manuscripts
<http://www.cell.com/misc/page?page=authors#RevisedSUB>*

*Checklist for Final Submission
<http://www.cell.com/misc/page?page=authors#Checklist> *

*Figure Formats for Publication
<http://www.cell.com/misc/page?page=authors#FinalFigs>*

*Production and Proofs
<http://www.cell.com/misc/page?page=authors#ProdProofs>*

*Leading Edge <http://www.cell.com/misc/page?page=authors#LeadingEdge>*

*Submission of Leading Edge Articles
<http://www.cell.com/misc/page?page=authors#LEsubmission> *

*Contacts at /Cell/ <http://www.cell.com/misc/page?page=authors#Contacts> *

*__*Aims and Scope

/Cell/ publishes findings of unusual significance in any area of
experimental biology, including but not limited to cell biology,
molecular biology, neuroscience, immunology, virology and microbiology,
cancer, human genetics, systems biology, signaling, and disease. The
basic criterion for considering papers is whether the results provide
significant conceptual advances into, or raise provocative questions and
hypotheses regarding, an interesting biological question. In addition to
primary  research articles in four formats
<http://www.cell.com/misc/page?page=authors#RAformats>, /Cell/ features
review and opinion articles on recent research advances and issues of
interest to its broad readership in the Leading Edge section
<http://www.cell.com/misc/page?page=authors#LeadingEdge>.

* ***

Back to Top <http://www.cell.com/misc/page?page=authors>

Editorial Evaluation Timeline

* *All submissions are initially evaluated in depth by the scientific
editors. Papers that do not conform to the general criteria for
publication will be returned to the authors without detailed review,
typically within 3-5 days. Otherwise, manuscripts will be sent to
reviewers who have agreed in advance to assess the paper rapidly. The
editors will make every effort to reach decisions on these papers within
3 weeks of the submission date. If revisions are a condition of
publication, we generally allow two months for revisions and consider
only one revised version of the paper.  Evaluations of conceptual
advance and significance are made based on the literature available on
the day of the final decision, not the day of submission.  Accepted
papers will be published within 3 months of acceptance. Any major
changes after acceptance are subject to review and may delay publication.

 Back to Top <http://www.cell.com/misc/page?page=authors>

*__Relationship between Cell Press Journals*

_Transfer of Papers between Cell Press Journals_

Each Cell Press journal is editorially independent. Cell Press has
developed a manuscript transfer policy designed to provide maximal
flexibility, efficiency, and control for the authors.  If a paper is
reviewed and rejected at one Cell Press journal, the Editor of that
journal can, upon the author’s request, make the reviews and reviewer
identities available to the Editor of another Cell Press journal. 
Authors interested in pursuing this option should email the Editor of
the second Cell Press journal directly.  In many cases the second Editor
will be able to reach a decision based on the advice of these reviewers.
In some cases he/she may need to seek comments from additional
reviewers.  The authors are also free to submit the paper to another
Cell Press title without mentioning the first review process, in which
case the manuscript will be evaluated by the Editor and, as appropriate,
reviewed independently without reference to the original reviews.

 

*_Cosubmission_*

In the limited number of instances where a paper is potentially
appropriate in scope for the readership of two different Cell Press
titles, the Cell Press journals also offer authors a unique opportunity
not provided by any other journal group to submit a manuscript for joint
consideration at two journals at the same time.  Authors interested in
pursuing this option should please contact the Editors of both journals
for further information. 

Back to Top <http://www.cell.com/misc/page?page=authors>

*__Editorial Policies*

Manuscripts are considered with the understanding that no part of the
work has been published previously in print or electronic format and the
paper is not under consideration by another publication or electronic
medium. All in-press or submitted works that are pertinent to the
manuscript under consideration by the journal (including those cited in
the manuscript under consideration) must accompany the submission.
Related manuscripts that have been submitted elsewhere during the period
of revision must accompany revised manuscripts.  Failure to provide
copies of related manuscripts under consideration elsewhere may delay
the review process and may be grounds for rejection.  Under no
circumstances will any paper be considered that contains any data that
have been submitted for publication elsewhere.

*_Authorship_*

The corresponding author is responsible for ensuring that all
appropriate contributors are listed as authors and that all authors have
agreed to the manuscript’s content and its submission to /Cell/. In a
case where we become aware of an authorship dispute, authorship must be
approved in writing by all of the parties.


  *_Conflict of Interest _*

/Cell/ requires all authors to disclose any financial conflict of
interest that might be construed to influence the results or
interpretation of their manuscript. Authors must declare any such
conflict in the cover letter accompanying the manuscript and in the
Acknowledgments section of the manuscript itself. The corresponding
author will be asked to sign a form on behalf of all the authors
regarding potential conflicts of interest at the time of acceptance. As
a guideline, any affiliation associated with a payment or financial
benefit exceeding $10,000 p.a. or 5% ownership of a company or research
funding by a company with related interests would constitute a conflict
that must be declared. This policy applies to all submitted research
manuscripts and review material.  Examples of statement language
include: AUTHOR is an employee and shareholder of COMPANY; AUTHOR is a
founder of COMPANY and a member of its scientific advisory board; This
work was supported in part by a grant from COMPANY.

 

*_Studies Involving Humans and Animals_*

For manuscripts reporting studies involving human subjects, statements
identifying the committee approving the studies and confirming that
informed consent was obtained from all subjects must appear in the
Experimental Procedures section.  All experiments on live vertebrates or
higher invertebrates must be performed in accordance with relevant
institutional and national guidelines and regulations. In the
manuscript, a statement identifying the committee approving the
experiments and confirming that all experiments conform to the relevant
regulatory standards must be included in the Experimental Procedures
section. The editors reserve the right to seek comments from reviewers
or additional information from authors on any cases in which concerns arise.

 


  *_Distribution of Materials and Data_*

One of the terms and conditions of publishing in /Cell/ is that authors
be willing to distribute any materials and protocols used in the
published experiments to qualified researchers for their own use. 
Materials include but are not limited to cells DNA, antibodies,
reagents, organisms, and mouse strains, or if necessary the relevant ES
cells. These must be made available with minimal restrictions and in a
timely manner, but it is acceptable to request reasonable payment to
cover the cost of maintenance and transport of materials.  If there are
restrictions to the availability of any materials, data, or information,
these must be disclosed in the cover letter and the Experimental
Procedures section of the manuscript at the time of submission.

Nucleic acid and protein sequences, macromolecular structures determined
by X-ray crystallography (along with structure factors), and microarray
data must be deposited in the appropriate public database
<http://www.cell.com/misc/page?page=misc5> and must be accessible
without restriction from the date of publication. An entry name or
accession number must be included as the last paragraph of the
Experimental Procedures section in the final version of the manuscript.
Microarray data should be MIAME compliant (for guidelines see
http://www.mged.org/Workgroups/MIAME/miame.html).

In addition to the information that must be deposited in public
databases as detailed above, authors are encouraged to contribute
additional information to the appropriate databases
<http://www.cell.com/misc/page?page=misc4>. Authors are also encouraged
to deposit materials used in their studies to the appropriate
repositories for distribution to researchers.

 

*_Open Archive_ *

Cell Press papers are freely available starting 12 months after
publication.

*_Copyright_*

Upon acceptance of an article, authors will be asked to transfer
copyright. This transfer will ensure the widest possible dissemination
of information. A form facilitating transfer of copyright will be
provided upon acceptance of the manuscript.  After transfer of
copyright, authors retain rights as discussed below.

*_Authors’ rights_*

As an author you (or your employer or institution) may do the following:

    * Make copies (print or electronic) of the article for your own
      personal use, including for your own classroom teaching use;
    * Make copies and distribute such copies (including through e-mail)
      of the article  to known research colleagues, for the personal use
      by such colleagues (but not for commercial purposes as described
      below);

    * Post a revised personal version of the final text (including
      illustrations and tables) of the article (to reflect changes made
      in the peer review and editing process) on your personal or your
      institutional website or server, with a link (through the relevant
      DOI) to the article as published, provided that such postings are
      not for commercial purposes as described below;
    * Present the article at a meeting or conference and to distribute
      copies of the article to the delegates attending such meeting;
    * For your employer, if the article is a ‘work for hire,’ made
      within the scope of your employment, your employer may use all or
      part of the information in the article for other intra-company use
      (e.g., training);
    * Retain patent and trademark rights and rights to any process or
      procedure described in the article;
    * include the article in full or in part in a thesis or dissertation
      (provided that this is not to be published commercially);
    * Use the article or any part thereof in a printed compilation of
      your works, such as collected writings or lecture notes
      (subsequent to publication of the article in the journal); and
    * Prepare other derivative works, to extend the article into
      book-length form, or to otherwise re-use portions or excerpts in
      other works, with full acknowledgement of its original publication
      in the journal.

 All copies, print or electronic, or other use of the paper or article
must include the appropriate bibliographic citation for the article’s
publication in the journal.  However you should not indicate in the
citation that the version that you are reproducing or posting is the
final published version as published in the journal.  As an example, it
may be appropriate to indicate “This paper has been submitted to
[Journal] for consideration.”

Commercial purposes include:  the posting by companies or their
employees for use by customers (e.g., pharmaceutical companies and
physician-prescribers); commercial exploitation such as associating
advertising with such posting (including the linking to advertising by
search engines); the charging of fees for document delivery or access;
or the systematic distribution to others via e-mail lists or list
servers (to parties other than known colleagues), whether for a fee or
for free.

 

*_US National Institutes of Health (NIH) Voluntary Posting Policy_*

Cell Press facilitates author posting in connection with the voluntary
posting request of the NIH (referred to as the NIH “Public Access
Policy,” see http://publicaccess.nih.gov/)  by submitting the
peer-reviewed author’s manuscript directly to PubMed Central on request
from the author, immediately after final publication. Please e-mail us
at NIHauthorrequest@elsevier.com that your work has received NIH funding
(with the NIH grant/project number(s), as well as name and e-mail
address of the Principal Investigator(s)) and that you intend to respond
to the NIH request. Upon such confirmation, Elsevier will submit to
PubMed Central on your behalf a version of your manuscript that reflects
changes made in the peer review process, for public access posting 12
months after the final publication date. This will ensure that you will
have responded fully to the NIH request policy. There will be no need
for you to post your manuscript directly to PubMed Central.

 

*_Permissions  _*

If excerpts from other copyrighted works are included in your
manuscript, you must obtain written permission from the copyright owners
and credit the sources in the article. To obtain permission to use
material from Cell Press and Elsevier journals and books, e-mail
permissions@elsevier.com.  If you have adapted a figure from a published
figure, please check with the copyright owners to see if permission is
required and include a complete citation/reference for the original
article.  Obtaining permissions can take up to several weeks.  As lack
of appropriate permissions can delay publication, we recommend that you
request permission at the time of submission.

 

Back to Top <http://www.cell.com/misc/page?page=authors>

*__Prepublication Publicity*

Work intended for submission to /Cell/, currently under consideration at
/Cell/, or in press at /Cell/ may not be discussed with the media before
publication. Providing preprints, granting interviews, discussing data
with members of the media, or participating in press conferences in
advance of publication without prior approval from the /Cell/ editorial
office may be grounds for rejection. With regards to the scientific
literature, papers in press in /Cell/ should not be discussed in reviews
elsewhere prior to the date of publication. Authors are welcome to
present and discuss material intended for publication in /Cell /at
scientific meetings; however, we do require that they refrain from
discussing the findings with members of the press beyond those included
in the formal presentation. In addition, we encourage meeting organizers
to contact our editorial office in advance of a meeting if they have any
questions regarding this policy. Any questions or issues regarding
prepublication publicity should be directed to the Press Officer of Cell
Press, Heidi Hardman (hhardman@cell.com).

 

*_Interaction with Members of the Press for Papers in Press_*

Authors are free to talk with the press starting on the Friday of the
week before publication and to release information provided that its use
is embargoed until noon Eastern Time on the day of online publication.
We also allow authors to discuss their work in press with other
scientific journals for purposes of coverage in review material. Please
refer any inquiries from other journals to us. If your press office
wishes to issue a press release, they should contact us in advance for
final embargo information.  Any questions or issues regarding
interaction with the press should be directed to the Press Officer of
Cell Press, Heidi Hardman (hhardman@cell.com).

 

Back to Top <http://www.cell.com/misc/page?page=authors>

*__Presubmission and Status Inquiries*

*_Presubmission Inquiries _*

If you would like editorial input on whether your paper might be a
strong candidate for consideration at /Cell/, you can send a
presubmission inquiry.  This should include an abstract plus a brief
description of the results and an explanation of the interest and
significance to the broad readership of /Cell/ and be emailed to
celleditor@cell.com.  We try to respond to these within 2-5 days.

 

*_Status Inquiries_*

Editorial Manager identifies the status as “with editor” until a
decision is made.  If you would like more information about the status
of your submitted manuscript, please email celleditor@cell.com or call
617-397-2825. 

 

Back to Top <http://www.cell.com/misc/page?page=authors>

 

*__Research Article Formats*

Research, Resource, Theory, and Matters Arising articles are all handled
through our online submission system, Editorial Manager, at
http://cell.edmgr.com/. A brief description of each article type is
provided below. Please refer to Preparation and Online Submission of
Research Manuscripts
<http://www.cell.com/misc/page?page=authors#SubmissionRA> for detailed
information about the organization of research articles and their
submission.

*_Research Articles_  *

Research Articles present conceptual advances of unusual significance
regarding a biological question of wide interest. Research papers should
be as concise as possible and written in a style that is accessible to
the broad /Cell/ readership. The total character count of an article
must be under 55,000 (including spaces, references, and figure legends),
and there should be no more than 7 figures and/or tables. Additional
items may be published online as Supplemental Data at the discretion of
the editor.

 

*_Resource Articles_*

The Resource format is designed to highlight significant technical
advances, and/or major informational databases that are of value and
interest to the broad /Cell/ readership. Resource articles are organized
like Research articles, have the same limits on length and figure/table
number, and should be presented to be accessible to the broad /Cell/
readership.

 

*_Theory Articles_*

The Theory format is intended for papers that employ computational,
theoretical, or analytical approaches to derive novel conceptual models
with clearly experimentally testable predictions. Like Research and
Resource articles, Theory papers must be of broad interest and written
in a manner accessible to the general reader. They follow the same
format and length guidelines as Research articles.

 

*_Matters Arising Articles_*

The Matters Arising format provides a venue for presenting a significant
challenge to a scientific model that was previously published in /Cell/.
They follow the same format and length as Research articles.

 

Back to Top <http://www.cell.com/misc/page?page=authors>

*__Article Preparation and Online Submission of Research, Resource,
Theory, and Matters Arising Articles*

*_Overview_*

/Cell /encourages authors to submit manuscripts via our online
submission system, Editorial Manager (http://cell.edmgr.com/) . An
author tutorial regarding online submission is available at the
Editorial Manager website. Authors may contact the editorial office
(celleditor@cell.com or 617-397-2825) for assistance. If you are unable
to submit your manuscript online, a copy of the manuscript may be sent
to Editor, /Cell/, Cell Press, 600 Technology Square, Cambridge, MA
02139, USA. Please include a CD with electronic files of text and
figures in the acceptable formats (see below
<http://www.cell.com/misc/page?page=authors#ImagesSUB>).

Editorial Manager will prompt you to upload the individual components of
your manuscript (cover letter, text, figures, supplemental data, etc.)
as separate files. Upon completion of this step, the website will build
a composite PDF file of your entire manuscript that will contain links
for the editors and reviewers to download the individual high-resolution
files of each component. Please note that the version of the PDF file
that is accessible to reviewers does not contain the cover letter; any
information therein will remain confidential.

Please be aware that Editorial Manager will send all communications
about the paper (including the request for final approval and the
confirmation of submission) to the person who is checked off as
corresponding author during the submission process, or if no name is
designated, to the person whose account is used to submit the
manuscript.  If you wish to specify a different author for editorial
correspondence after submission please contact the editorial assistant
at celleditor@cell.com. 

*_Cover Letter _*

Each submission should be accompanied by a cover letter, which should
contain a brief explanation of what was previously known, the conceptual
advance provided by the findings, and the significance of the findings
to a broad readership. A cover letter may contain suggestions for
appropriate reviewers and up to three requests for reviewer exclusions.
The cover letter is confidential to the editor and will not be seen by
reviewers.

 

*_General Article Organization and Text Specifications_*

/Cell/ Research articles generally contain the following sections in
this order: Title, Authors, Affiliations, Contact Information,
Additional title page Footnotes, Summary, Introduction, Results,
Discussion, Experimental Procedures, Acknowledgements, References,
Figure and Table Legends, Figures and Tables, Supplemental Data.  The
text (Title through Legends) should be provided as one document, which
may also contain the Tables.  Figures should be provided separately.
Supplemental Data should be provided separately.

The total character count of the main text, including all sections and
including spaces but excluding supplemental data, should not exceed
55,000. An article may contain up to 7 figures and/or tables. Gene
symbols should be italicized; protein products of the loci are not
italicized. Nonstandard abbreviations should be defined when first used
in the text. Use of abbreviations should be kept at a minimum.
Manuscript file types that we can accept for submission include Word,
RTF, and TXT. Required items differ for each article type and are
specified during the submission process.

Please note that the text should be double spaced and pages should be
numbered. Although summaries need to be entered as text files separate
from the body of the manuscript during the online submission process,
they should also be included within the manuscript file as usual.

*Manuscripts that do not conform to the format guidelines may be
returned to the authors for reformatting. *

*_Preparation of Specific Sections_*

*_Title _*/
/Titles can occupy no more than three lines of type. Each line should
contain no more than 38 characters, including spaces. The title should
convey the conceptual significance of the paper to a broad readership.

*_Authors/Affiliations_*/
/Author names should be spelled out rather than set in initials. Authors
should be footnoted to corresponding affiliations. Affiliations should
contain the following core information: department(s)/subunit(s);
institution; city, state/region, postal code; country.

*_Contact_*

The contact line should include the email address and phone/fax numbers
of the corresponding author. The published corresponding author is
responsible for ensuring adherence to all editorial and submission
policies and for any communications that may result post-publication.
 One corresponding author is preferred, but two are allowed.

*_Additional Footnotes_*/
/Footnotes are only allowed on page 1 of the text (and in tables). They
may include a present address or statement of equal contribution to the
manuscript.

_*Summary*_/
/The Summary consists of a single paragraph of fewer than 150 words. It
should clearly convey the conceptual advance and significance of the
work to a broad readership. In particular, the abstract should contain a
brief background of the question, a description of the results without
extensive experimental detail, and a summary of the significance of the
findings. References should not be cited in the Summary.

*_Introduction_*/
/The Introduction should be succinct, with no subheadings, and should
present the background information necessary to provide a biological
context for the results.

*_Results_*

This section should be divided with subheadings. Footnotes should not be
used and will be transferred to the text.

_*Discussion*_

The Discussion should explain the significance of the results and place
them into a broader context. It should not be redundant with the Results
section. This section may contain subheadings and can in some cases be
combined with the Results section.

 

*_Experimental Procedures_*/
/The Experimental Procedures section needs to include sufficient detail
so that readers can understand how the experiments were done, and so
that all procedures can be repeated, in conjunction with cited
references. This section should also include a description of any
statistical methods employed in the study. A more detailed version of
the procedures and details such as oligo sequences, strains, and
specifics of how constructs were made can be included in Supplemental
Data, but it is not appropriate to move the majority of the Experimental
Procedures to Supplemental Data in order to shorten the text. 

*_Acknowledgments_*

This section may acknowledge contributions from non-authors, list
funding sources, and should include a statement of any conflict of
interests.  Please check this section carefully, as we are unlikely to
make amendments or publish corrections post-publication.  This section
may be used to list the contributions of individual authors.

_*References*_

References should include only articles that are published or in press.
Unpublished data, submitted manuscripts, abstracts, and personal
communications should be cited within the text only. Personal
communication should be documented by a letter of permission. Submitted
articles should be cited as unpublished data, data not shown, or
personal communication. Note: "et al." should only be used after 10
authors. Please use the following style for references:

_Article in a periodical_: Sondheimer, N., and Lindquist, S. (2000).
Rnq1: an epigenetic modifier of protein function in yeast. Mol. Cell
/5/, 163-172.

_Article in a book_: King, S.M. (2003). Dynein motors: Structure,
mechanochemistry and regulation. In Molecular Motors, M. Schliwa, ed.
(Weinheim, Germany: Wiley-VCH Verlag GmbH), pp. 45–78.

_An entire book_: Cowan, W.M., Jessell, T.M., and Zipursky, S.L. (1997).
Molecular and Cellular Approaches to Neural Development (New York:
Oxford University Press).

_*Figure Legends*_/
/Legends should be included in the submitted manuscript as a separate
section. Each figure legend should have a brief title that describes the
entire figure without citing specific panels, followed by a description
of each panel. For any figures presenting pooled data, the measures
should be defined in the figure legends (for example, data are
represented as mean +/- SEM). 

*_Tables_*

When creating a table, please use the Microsoft Word table function and
do not place an Excel table in a Word document. Word tables should not
be tab or space delineated and should not use color. Tables should
include a title, and footnotes and/or legend should be concise. Include
tables in the submitted manuscript as a separate section. Tables not
created using the Microsoft Word table function will need to be revised
by the author.  

 

_*Supplemental Data*_/
/Supplemental data are restricted to items that are directly pertinent
to the conclusions of the paper.  Editors reserve the right to limit the
scope and length of Supplemental Data.  Supplemental Data should be
provided with the original submission.  Please follow the digital figure
guidelines <http://www.cell.com/misc/page?page=authors#FigureFormats>
below for preparing figures.  In general, supplemental files (movies,
databases, tables, etc.) must each be less than 10 MB.  All figures and
tables should have titles and legends.  In general, every attempt should
be made to submit the Supplemental Data in a composite Word file. 

_*Supplemental Movies and Excel Spreadsheets *_

Supplemental movies may be submitted through Editorial Manager as .mov,
.avi, .mpeg, or .gif files. By choosing the submission item labeled
"Supplemental Movies and Spreadsheets," the PDF builder will imbed links
within the PDF where editors and reviewers will be able to download the
files. This also works for Excel files that do not display properly once
converted to a PDF. Please note that the size limit for these items is
10 MB per file.

If you have supplemental movies or spreadsheets over 10 MB in size, we
ask that you send the files on four CDs to our offices at 600 Technology
Square, fifth floor, Cambridge, MA 02139.

 

 

*Figure Organization, Formats, and Style*

Figures must conform to the following guidelines or authors will be
asked to revise them. For figures that have multiple panels, the labels
should be set in uppercase Helvetica or Arial letters and should not
contain periods or parentheses. Please be sure to embed all fonts. Each
figure must be assembled into one file that prints onto one 8 1/2 × 11
page. Please do not include separate panels on multiple pages.
Micrographs should be provided with a scale bar, if appropriate, instead
of magnification.

Back to Top <http://www.cell.com/misc/page?page=authors>

_*Acceptable Image Formats for Online Submission: *_

    *

      TIFF (.tif)

    *

      Encapsulated Postscript (.eps)

    *

      Portable Document File (.pdf)

    *

      JPEG (.jpg) – use maximum quality

*_Please note that we cannot accept /PowerPoint/,_* _*/Adobe Photoshop/,
or /Adobe Illustrator/ files for online submission through Editorial
Manager.*_

These files must be converted to one of the above file types. Converting
/PowerPoint/ files frequently results in unexpected changes to the
figures (e.g., missing or shifted text; shifted image elements). We
recommend that you not create figures in PowerPoint.  If you do try to
convert from PowerPoint to one of these file types, be very careful to
compare the final version to your original.

*We also cannot accept image files in /Canvas/, /Freehand,/ or
/Microsoft Word/. *

*TIFF Files (.tif)*

TIFF is our preferred format.

*Encapsulated Postscript Files (.eps)*

As with all vector files (Adobe Illustrator, etc.), when saving as .eps,
please be sure to embed all fonts or convert to outlines or paths.

*Postscript Files (.ps)*

There are many different drawing programs, not all of them supported by
the software we use. From almost all of these programs, you should be
able to produce a postscript file. When printing, select to print to a
(postscript) file, rather than printing by default to a printer. The
image must be in portrait orientation. Please be sure to embed all fonts
when you save as postscript.

_*Resolution Requirements*_

For black and white photographs or micrographs and for any type of graph
or drawing in grayscale, the resolution of your file should be a minimum
of 500 dpi. For figures that contain color, the resolution should be a
minimum of 300 dpi. Please note that figures should meet these
resolution numbers at their approximate print sizes.

_*Color Images*_

We encourage authors to use colors that can be distinguished by
color-blind readers. Please submit your figures in RGB or grayscale --
do not convert your files to CMYK. This will optimize their appearance
online. However, please be aware that we will convert to CMYK for the
print version. If possible, embed the ICC profile.

_*Line Weights*_

Please make sure that all graph lines, error bars, and outlines are at
least ½ point in weight. Lines that are less than ½ point may disappear
or be broken during printing.

If you have any questions about digital files, please contact Meredith
Adinolfi, Senior Managing editor of /Cell/, at madinolfi@cell.com.

Back to Top <http://www.cell.com/misc/page?page=authors>

*__Submission of Revised Manuscripts *

 

In addition to the sections described above, revised manuscripts must
also contain a detailed point by point response to the comments of the
reviewers and/or editors. The cover letter should briefly summarize how
the revised manuscript addresses these comments. In general, revised
manuscripts will be reconsidered only if resubmitted within two months
of the date of the original decision.

 

Back to Top <http://www.cell.com/misc/page?page=authors> 

*__Checklist for Final Submission*

 

In order for a paper to be accepted and scheduled for publication, the
author will be asked to send the following items.  Please refer to the
letter from your editor for further details and to the additional
guidelines below for final figures
<http://www.cell.com/misc/page?page=authors#FinalFigs>.

*_1. Please make sure your final manuscript:_*

    *

      Meets our length restrictions of 55,000 characters, including
      spaces, and 7 figures and/or tables

    *

      Includes database accession numbers for new gene sequences,
      protein sequences, structures, or microarray data

    *

      Includes explanation of statistical methods in the Experimental
      Procedures

    *

      For any figures presenting pooled data, defines the measures in
      the figure legends

    *

      Includes experimental procedures of sufficient detail

 

*_2. Please submit the final version of text and figures through our
online system._*

*_3. Please send to us:_*

In hard copy:

    *

      One printed copy of the text

    *

      Two high-quality glossy hard copies of each figure (including
      supplemental)

    *

      A signed copy of the conflict of interest statement

 

On a single CD:

    *

      A modifiable electronic version of the final text

    *

      High-resolution digital files of the figures in an accepted format

    *

      Supplemental dataset as a single Word document with embedded
      figures and tables

    *

      Additional supplemental data such as movies and spreadsheets

    *

      A short paragraph of 100 words describing the context and
      significance of the findings, to be adapted for email alerts and
      In this Issue pages

 Back to Top <http://www.cell.com/misc/page?page=authors>

*Figure Formats Acceptable for Final Submission:*

 

    *

      TIFF (.tif)

    *

      Encapsulated Postscript (.eps)

    *

      Postscript (.ps)

    *

      Portable Document File (.pdf)

    *

      JPEG (.jpg) – use maximum quality

    *

      PhotoShop (all versions) (.psd)

    *

      Adobe Illustrator (all versions) (.ai)

*Please note that we cannot accept /PowerPoint/ files.* (See note under
_Figure Organization, Formats, and Style_
<http://www.cell.com/misc/page?page=authors#ImagesSUB> above).* *

*/ /*

*_File Naming_*

Please name files by first author and number of figure, e.g.,
Smith1.tif, Smith2.tif, etc.

 

Back to Top <http://www.cell.com/misc/page?page=authors>

 

*__Production and Proofs*

After final acceptance, the manuscript will be passed to the production
team to be copyedited and prepared for printing.  Authors will be
charged $1000 for the first color figure and $250 for each additional
color figure. Figures may be resized during the production process.

PDF proofs will arrive via email about 2 weeks prior to publication and
need to be returned with vital corrections no more than 24 hours after
receipt. If you will be unreachable at all during this period or
anticipate any problems meeting this timeline, please contact Meredith
Adinolfi, Senior Managing Editor (madinolfi@cell.com).

Back to Top <http://www.cell.com/misc/page?page=authors>

*__Leading Edge *

/Cell/’s Leading Edge presents scholarly, thought-provoking opinion and
review style articles that provide a balanced overview and fresh outlook
on exciting research advances and scientific policy issues of interest
to /Cell/’s broad readership. Leading Edge contains both traditional
formats—Previews, Minireviews, and Reviews—and several new formats
including Commentaries, Essays, and Correspondence. Leading Edge
articles should be written in an engaging, accessible style bearing in
mind the broad readership of /Cell/. The majority of Leading Edge
articles are commissioned, but we do accept presubmission inquiries
about proposed timely contributions.

 

*__Leading Edge Formats*

 

*_Commentaries_*

Commentary articles are opinion pieces that discuss issues—such as
science policy, research funding, bioethics—that affect research in the
biological sciences. Commentaries are 2000 to 3000 words in length (with
a 2-sentence abstract), 10 or fewer references, and one or two figures
where appropriate.

* *

*_Essays_*

Essays are concise opinion pieces that provide fresh insights into
published scientific data. They may contain more speculation than
traditional formats. Essays may also take a historical perspective,
discussing a landmark paper from long ago and highlighting what we can
learn from the scientific accomplishments of the past. Essays are 2000
to 3000 words in length (with a 2-sentence abstract), 15 or fewer
references, and one or two figures.

* *

*_Correspondence_*

The Correspondence format provides our readers with the opportunity to
respond to an article in /Cell/—either a research article or Leading
Edge article—that has been published within the last 2 months.
Correspondence should be no more than 900 words in length with up to 5
references and should be of interest to the broad readership, providing
new information or a fresh perspective on the published article. If
selected for publication, the Correspondence will be sent to the authors
of the published article for a response.

*_Meeting Reports_*

/Cell/ occasionally publishes reports that present the important themes
of a recent conference that has relevance for /Cell/ readers. Meeting
reports are 2000 to 4000 words (with a 30-word abstract), 20 or fewer
references, and one or two figures if appropriate and must be submitted
within one month of the conference.

* *

*_Previews_*

Previews highlight one or several research papers published in the same
issue of /Cell/ or in a recent issue of another journal, placing the
results in context for /Cell/’s broad readership. Previews are usually
1200 to 1500 words in length (with a 2-sentence abstract), no more than
10 references, and one figure.  Most Previews are commissioned, but
timely unsolicited contributions will be considered.

*_Minireviews_*

Minireviews discuss a sharply focused scientific topic of interest,
usually highlighting emerging themes from papers in the recent
literature. Minireviews must fit within 4 pages of the journal and
therefore can be no more than 3500 words in length (including figure
legends, a 40-word abstract, and no more than 20 references) and may
include one or two figures.

*_Reviews_*

Leading Edge publishes full-length reviews on topics of interest to
/Cell/’s broad readership. Reviews are usually 5000 to 8000 words in
length (including an abstract that is no more than 100 words), up to 75
references, and 3 to 5 figures.

  

Back to Top <http://www.cell.com/misc/page?page=authors>

*__Submission of Leading Edge Articles*

Leading Edge articles should be submitted as word files by email to the
Leading Edge editor who commissioned the article.

*_Figures_*

We welcome the use of figures to illustrate and enhance the text of
Leading Edge articles. Figures should be submitted by email to the
commissioning editor as graphics files. They should be either Photoshop
or Illustrator files (in tiff, psd, eps, ai, pdf, or JPEG formats) at
300 dpi resolution (for a figure 3 to 5 inches in width). Our
professional in-house illustrator will work with authors to ensure the
highest quality and clarity of published figures.

*_Presubmission Inquiries_*

Presubmission inquiries should contain an outline of the proposed
article and an explanation of the interest and significance to the broad
readership of /Cell/. Presubmission inquiries should be submitted to
celleditor@cell.com or to the Leading Edge Editor osmith@cell.com.

 

Back to Top <http://www.cell.com/misc/page?page=authors>

*__Contacts at /Cell/ *

**

*Presubmission inquiries: *celleditor@cell.com

*Assistance with online submission: *617-397-2825 or celleditor@cell.com

*Leading Edge questions*: celleditor@cell.com or osmith@cell.com

*Status inquiries about submitted papers and Leading Edge articles:* 
celleditor@cell.com

*Proofs:* Meredith Adinolfi, Senior Managing Editor, madinolfi@cell.com

*Prepublication publicity and press issues:* Erin Doonan, Press Officer,
edoonan@cell.com

*Permissions: *permissions@elsevier.com

Back to Top <http://www.cell.com/misc/page?page=authors>


        cell <http://www.cellpress.com/>

    * Cancer Cell <http://www.cancercell.org/>
    * Cell <http://www.cell.com/>
    * Cell Host & Microbe <http://www.cellhostandmicrobe.com/>
    * Cell Metabolism <http://www.cellmetabolism.org/>
    * Cell Stem Cell <http://www.cellstemcell.com/>
    * Chemistry & Biology <http://www.chembiol.com/>

    * Current Biology <http://www.current-biology.com/>
    * Developmental Cell <http://www.developmentalcell.com/>
    * Immunity <http://www.immunity.com/>
    * Molecular Cell <http://www.molecule.org/>
    * Neuron <http://www.neuron.org/>
    * Structure <http://www.structure.org/>

Copyright 2007 Elsevier Inc. | Privacy Policy
<http://www.cellpress.com/misc/page?page=privacy_policy> | Terms and
Conditions <http://www.cellpress.com/misc/page?page=Termsandconditions>
| SiteMap <http://www.cell.com/misc/page?page=sitemap>

